Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical, demographic, and MSCT data of the entire MSCT cohort (n = 67)

From: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

   Entire cohort (n = 67)
Women [n,%] 35, 52%
Median age (range) [years] 61 (21 – 87)
Median BMI (range) [kg/m2] 24 (17 – 53)
Median time ESRD (range) [months] 49 (2 – 364)
Previous renal transplant [n,%] 21, 31%
Current smoking [n,%] 10, 15%
History of CVD [n,%] 25, 37%
History of CAD [n,%] 22, 33%
Diabetes [n,%] 15, 22%
History of PAD [n,%] 9, 13%
History of MI [n,%] 9, 13%
History of PTex [n,%] 9, 13%
Median CAC Agatston (range) (n = 65)   279 (0 – 3736)
Median Mass CAC (range) (n = 65)   51 (0 – 643)
Median Volume CAC (range) (n = 65)   261 (0 – 3267)
Median AVC Agatston (range)   0 (0 – 1596)
Median Mass AVC (range)   0 (0 – 284)
Median Volume AVC (range)   0 (0 – 1316)
CAC Agatston score >100 [n,%] 44, 66%
Any AVC [n,%] 27, 40%
Usage of Phosphate binders [n,%] 61, 92%
Calcium-based [n,%] 51, 77%
Aluminum-based [n,%] 14, 22%
Calcimimetics [n,%] 16, 25%
  1. Abbreviations: AVC aortic valve calcification; BMI body mass index; CAC coronary artery calcification; CAD coronary artery disease; CVD cerebrovascular disease; ESRD end-stage renal disease; MI myocardial infarction; MSCT multi-sclice computed tomography; PAD peripheral arterial disease; Ptex parathyroidectomy.